Moreover, although IL-6 immunoreactivity was not upregulated in the MetS + RAS group vs. the Lean group, it was significantly lower in the MetS + RAS + MSC group compared to the MetS + RAS group. This evidence concerns the gene IL6 and metabolic syndrome.